1
SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity
Condition(s):OtotoxicityLast Updated:March 17, 2021Enrolling by invitation
Ototoxicity: 42 Clinical Trials, Page 1 of 5
Hide Studies Not Open or Pending
2
Prevention of Drug Induced Ototoxicity in Peritoneal Dialysis Patients by N-Acetylcysteine
Condition(s):Drug-induced Ototoxicity in Peritoneal Dialysis PatientsLast Updated:May 27, 2010Completed
3
Randomized Trial Comparison of Ototoxicity Monitoring Programs
Condition(s):Cisplatin Ototoxicity; Hearing LossLast Updated:October 9, 2019Completed
4
The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in Humans
Condition(s):Ototoxicity; Hearing LossLast Updated:June 8, 2010Completed
5
Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?
Condition(s):Hearing Loss; OtotoxicityLast Updated:December 21, 2007Unknown status
6
Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
Condition(s):OtotoxicityLast Updated:March 23, 2022Recruiting
7
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
Condition(s):Ototoxicity; Unspecified Childhood Solid Tumor, Protocol SpecificLast Updated:March 13, 2017Completed
8
Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Condition(s):Osteosarcoma; Nephrotoxicity; OtotoxicityLast Updated:March 16, 2020Completed
9
Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin
Condition(s):Ototoxicity; Unspecified Adult Solid TumorLast Updated:March 7, 2014Completed
10
Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children With Average-Risk Medulloblastoma and Reduced Therapy in Children With Medulloblastoma With Low-Risk Features
Condition(s):Medulloblastoma; Ototoxicity; Anaplastic Medulloblastoma; Large Cell MedulloblastomaLast Updated:May 19, 2022Not yet recruiting